These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30410442)

  • 1. Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin.
    Zhang J; Chen Y; Luo H; Sun L; Xu M; Yu J; Zhou Q; Meng G; Yang S
    Front Pharmacol; 2018; 9():1204. PubMed ID: 30410442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between iron and dihydromyricetin extracted from vine tea.
    Wang L; Qin Y; Wang Y; Zhou Y; Liu B
    Food Sci Nutr; 2020 Nov; 8(11):5926-5933. PubMed ID: 33282244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytochemicals protect L02 cells against hepatotoxicity induced by emodin
    Yan Y; Wang K; Tang X; Gao JF; Wen BY
    Toxicol Res (Camb); 2019 Nov; 8(6):1028-1034. PubMed ID: 32153769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
    Tong H; Zhang X; Tan L; Jin R; Huang S; Li X
    Eur J Pharmacol; 2020 Mar; 870():172888. PubMed ID: 31866404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability.
    Liu D; Mao Y; Ding L; Zeng XA
    Trends Food Sci Technol; 2019 Sep; 91():586-597. PubMed ID: 32288229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral hygiene might prevent cancer.
    Cordero OJ; Varela-Calviño R
    Heliyon; 2018 Oct; 4(10):e00879. PubMed ID: 30417145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases.
    Martínez-Coria H; Mendoza-Rojas MX; Arrieta-Cruz I; López-Valdés HE
    Front Pharmacol; 2019; 10():1334. PubMed ID: 31780947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
    Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
    Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy.
    Wu JZ; Ardah M; Haikal C; Svanbergsson A; Diepenbroek M; Vaikath NN; Li W; Wang ZY; Outeiro TF; El-Agnaf OM; Li JY
    Transl Neurodegener; 2019; 8():18. PubMed ID: 31223479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer's Diseases.
    Liu M; Guo H; Li Z; Zhang C; Zhang X; Cui Q; Tian J
    Front Aging Neurosci; 2020; 12():601603. PubMed ID: 33192493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydromyricetin Attenuates Inflammation through TLR4/NF-kappaB Pathway.
    Jing N; Li X
    Open Med (Wars); 2019; 14():719-725. PubMed ID: 31572805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p/PTEN signaling in diabetic nephropathy.
    Guo L; Tan K; Luo Q; Bai X
    Bosn J Basic Med Sci; 2020 Aug; 20(3):372-380. PubMed ID: 31668144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis.
    Cheng QC; Fan J; Deng XW; Liu HC; Ding HR; Fang X; Wang JW; Chen CH; Zhang WG
    World J Gastroenterol; 2020 Nov; 26(41):6346-6360. PubMed ID: 33244197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism.
    Silva J; Yu X; Moradian R; Folk C; Spatz MH; Kim P; Bhatti AA; Davies DL; Liang J
    Alcohol Clin Exp Res; 2020 May; 44(5):1046-1060. PubMed ID: 32267550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin affect the pharmacokinetics of triptolide in rats.
    Deng Y; Guo L; Cai H; Chen L; Tan S; Zhang B; Fang P; Xiang D; Li H; He G; Yan M
    Xenobiotica; 2020 Mar; 50(3):332-338. PubMed ID: 31092113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis
    Chen L; Yang ZS; Zhou YZ; Deng Y; Jiang P; Tan SL
    J Cancer; 2020; 11(19):5689-5699. PubMed ID: 32913463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
    Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
    Chen J; Wang X; Xia T; Bi Y; Liu B; Fu J; Zhu R
    Biomed Pharmacother; 2021 Oct; 142():111927. PubMed ID: 34339914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydromyricetin alleviates acetaminophen-induced liver injury via the regulation of transformation, lipid homeostasis, cell death and regeneration.
    Dong S; Ji J; Hu L; Wang H
    Life Sci; 2019 Jun; 227():20-29. PubMed ID: 30974116
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.